156 related articles for article (PubMed ID: 16944372)
1. A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes.
Sakata K; Someya M; Nagakura H; Nakata K; Oouchi A; Hareyama M; Satoh M
Strahlenther Onkol; 2006 Sep; 182(9):511-7. PubMed ID: 16944372
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
3. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
4. Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?
Mayer A; Höckel M; Vaupel P
Strahlenther Onkol; 2006 Sep; 182(9):501-10. PubMed ID: 16944371
[TBL] [Abstract][Full Text] [Related]
5. Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix.
Mayer A; Wree A; Höckel M; Leo C; Pilch H; Vaupel P
Cancer Res; 2004 Aug; 64(16):5876-81. PubMed ID: 15313932
[TBL] [Abstract][Full Text] [Related]
6. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
7. Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers.
Mayer A; Höckel M; Wree A; Vaupel P
Clin Cancer Res; 2005 Apr; 11(7):2768-73. PubMed ID: 15814659
[TBL] [Abstract][Full Text] [Related]
8. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia.
Nakano T; Suzuki Y; Ohno T; Kato S; Suzuki M; Morita S; Sato S; Oka K; Tsujii H
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2185-90. PubMed ID: 16609033
[TBL] [Abstract][Full Text] [Related]
9. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.
Raleigh JA; Chou SC; Calkins-Adams DP; Ballenger CA; Novotny DB; Varia MA
Clin Cancer Res; 2000 Mar; 6(3):855-62. PubMed ID: 10741707
[TBL] [Abstract][Full Text] [Related]
10. Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: a pilot study in men with prostate cancer.
Chopra S; Foltz WD; Milosevic MF; Toi A; Bristow RG; Ménard C; Haider MA
Int J Radiat Biol; 2009 Sep; 85(9):805-13. PubMed ID: 19728195
[TBL] [Abstract][Full Text] [Related]
11. Lack of apoptotic protease activating factor-1 expression and resistance to hypoxia-induced apoptosis in cervical cancer.
Leo C; Horn LC; Rauscher C; Hentschel B; Richter CE; Schütz A; Leo CP; Höckel M
Clin Cancer Res; 2007 Feb; 13(4):1149-53. PubMed ID: 17317823
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.
Hoogsteen IJ; Marres HA; Bussink J; van der Kogel AJ; Kaanders JH
Head Neck; 2007 Jun; 29(6):591-604. PubMed ID: 17252597
[TBL] [Abstract][Full Text] [Related]
13. Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia.
Lyng H; Sundfør K; Rofstad EK
Radiother Oncol; 1997 Aug; 44(2):163-9. PubMed ID: 9288845
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
Hellberg D; Tot T; Stendahl U
Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
[TBL] [Abstract][Full Text] [Related]
15. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
[TBL] [Abstract][Full Text] [Related]
16. Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements.
Höckel M; Schlenger K; Knoop C; Vaupel P
Cancer Res; 1991 Nov; 51(22):6098-102. PubMed ID: 1933873
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.
Nordsmark M; Loncaster J; Aquino-Parsons C; Chou SC; Gebski V; West C; Lindegaard JC; Havsteen H; Davidson SE; Hunter R; Raleigh JA; Overgaard J
Radiother Oncol; 2006 Aug; 80(2):123-31. PubMed ID: 16890316
[TBL] [Abstract][Full Text] [Related]
18. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
Varia MA; Calkins-Adams DP; Rinker LH; Kennedy AS; Novotny DB; Fowler WC; Raleigh JA
Gynecol Oncol; 1998 Nov; 71(2):270-7. PubMed ID: 9826471
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia in head and neck cancer: how much, how important?
Janssen HL; Haustermans KM; Balm AJ; Begg AC
Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
